Clinicaltrialvanguard

Published October 24, 2026

Perspective Therapeutics' [212Pb]VMT-α-NET shows responses in neuroendocrine tumor trial

Read the full story at Clinicaltrialvanguard

Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site ... press release and investor presentation rather than in the 8-K itself.